Interleukin-17 Receptor A Antagonist [EPC] - N0000193276
Pharmacologic Class Information
Pharmacologic Code | N0000193276 |
Pharmacologic Name | Interleukin-17 Receptor A Antagonist |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Interleukin-17 Receptor A Antagonist
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Interleukin-17 Receptor A Antagonist [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0187-0004 | Siliq | Non-Proprietary Name: Brodalumab | Injection | Subcutaneous | Bausch Health Us Llc | ACTIVE |